CoDa Therapeutics (New Zeland) -based drug company focused on Nexagon, a wound care and tissue repair therapeutic, raised a $20M Series A financing. The round was led by Domain Associates and GBS Venture Partners.
OnBioVC
From the A to the Exit: What is Happening in Bio VC
The Plan for OnBioVC
Adam Rubenstein - Boulder, CO OnBioVC is an effort to aggregate and organize all that is transpiring in early and late stage life science investing. Contact me at: arubenstein@rnaventures.comYour Ad Could Be Here!
I’m Going to BioWest!
Are You?Categories
- 1- My Rants
- 2- Q'ly Summaries
- 3 – Help Wanted
- I – Series A
- I – Series B
- I – Series C
- I – Series D
- I – Series E
- I – Series F
- I – Series G
- Q – 1Q08
- R – INTERNATIONAL
- R – MID WEST
- R – MID-ATLANTIC
- R – NORTH EAST
- R – NORTH WEST
- R – ROCKY MOUNTAIN
- R – SOUTH EAST
- R – SOUTH WEST
- R – WEST
- X – ADHD
- X – Antibacterial
- X – Antiviral
- X – Asthma
- X – Autoimmune Disease
- X – Biologics Mfg.
- X – Cardiology
- X – CF
- X – CRO
- X – Crohns
- X – Cytomegalovirus
- X – Dermatology
- X – Device (Biopsy)
- X – Device (Cardiology)
- X – Device (Diabetes)
- X – Device (Diagnostic)
- X – Device (Endoscopy)
- X – Device (Fluid Assay)
- X – Device (Fluidics)
- X – Device (Imaging)
- X – Device (Neuromod)
- X – Device (Ophthal)
- X – Device (Orthopedic)
- X – Device (Sequencing)
- X – Device (Spine)
- X – Diabetes
- X – Diagnostic
- X – GI
- X – Hepatitis C
- X – HIV
- X – IBD
- X – Inflammation
- X – Insomnia
- X – Microarray
- X – Multiple Sclerosis
- X – Muscular Dystrophy
- X – Oncology
- X – Opthalmology
- X – Orthopedic
- X – Pain
- X – Plasma
- X – Psoriasis
- X – Renal
- X – Shingles
- X – Therapeutic Platform
- X – Vaccines
- X – Wound Healing
Archives
Theme Contempt by Vault9.
Blog at WordPress.com.
